Insilico Medicine vs Superhuman

Insilico Medicine — Application · Public · $4.3B mkt cap · 5 of 5 figures sourced  |  Superhuman — Application · Private · 1 of 1 figure sourced

Relationship

Science42: DORA and Grammarly do comparable work on summarization; both also serve buyers who need to draft and edit written content; Superhuman's scale not recorded.

Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.

3 of 8 capabilitiesShared product type

3 of 8 capabilities — Shares agent orchestration, summarization and text generation.

Ludbee capability tags · from the product records

Shared product type — Both ship application and platform.

Ludbee product records

Aligned comparison

FieldInsilico MedicineSuperhuman
Size$4.3B mkt capnot disclosed
Employees333—
Founded20142009 5 yrs earlier
StatusPublicPrivate
CategoryApplicationApplication match
Stack layerApplication, Hardware, PlatformApplication, Platform
HeadquartersHong KongSan Francisco, USA

Capability overlap

Shared · 3

Agent orchestrationSummarizationText generation

Not verified for Superhuman · 5

Data analysisDrug discoveryEvaluation and observabilityModel trainingKnowledge retrieval

Recorded for Insilico Medicine. Superhuman’s product records say nothing either way — a missing record is not a missing capability.

Not verified for Insilico Medicine · 2

Email assistanceWorkflow automation

Recorded for Superhuman. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.

Products, side by side

Algorithmic pairing — assembled from recorded fields, not hand-checked

Insilico Medicine

Application

Science42: DORAApplication

AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.

inClinicoApplication

Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.

Platform

Biology42: Generative BiologicsPlatform

AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.

Chemistry42Platform

Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.

MMAI GymPlatform

Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.

PandaOmicsPlatform

AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.

Pharma.AIPlatform

End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.

Superhuman

Application

GrammarlyApplication

The writing assistant that gave the company its old name: spelling, grammar and tone correction across a million apps and websites, with generative rewrites, plagiarism and AI-text detection on the paid tier.

Superhuman DocsApplication

A collaborative-docs surface where a team's data and AI meet, the renamed successor to the acquired Coda.

Superhuman GoApplication

An AI assistant that works across the applications a person already uses, rather than living in its own chat window.

Superhuman MailApplication

An AI-assisted email client, the product the company was originally named for, now sold as one app inside the Superhuman Platform.

Platform

Superhuman PlatformPlatform

The umbrella under which Superhuman now sells Mail, Docs and Go as one subscription, plus a marketplace of third-party agents and connectors.

No counterpart

Insilico Medicine sells these in a stack layer with no product recorded for Superhuman yet — nothing on the other side to compare them against.

Hardware

PandaOmics BoxHardware

On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.